Amyloid beta (Aβ) binding alcohol dehydrogenase (ABAD) is a cellular cofactor for promoting (Aβ)-mediated mitochondrial and neuronal dysfunction and cognitive decline in transgenic Alzheimer’s disease (AD) mouse models. levels suggesting protective mitochondrial function effects of these synthesized compounds. Thus these compounds are potential candidates for further pharmacologic development to target ABAD to improve mitochondrial function.… Continue reading Amyloid beta (Aβ) binding alcohol dehydrogenase (ABAD) is a cellular cofactor